Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?
- PMID: 39775474
- DOI: 10.1007/s40272-024-00678-y
Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?
Conflict of interest statement
Declarations. Funding: This project was not funded. Conflict of interest: C. A. Maiwald has a financial relationship in the profits of the Neofact® product as inventor (Murrplastik Medizintechnik GmbH, Germany) and his research projects on LISA are, in part, supported by Lyomark Pharma GmbH, Germany. Karel Allegaert is an Editorial Board member of Pediatric Drugs. Karel Allegaert was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Availability of data and materials: Not applicable. Consent to participate: Not applicable. Code availability: Not applicable. Author contributions: CAM and KA drafted the first version of the manuscript in cooperation and both made important contributions from their research perspective. Both reviewed and approved the final version of the manuscript.
Comment on
-
Dexmedetomidine for Less Invasive Surfactant Administration: A Pilot Study.Paediatr Drugs. 2025 Mar;27(2):247-255. doi: 10.1007/s40272-024-00667-1. Epub 2024 Nov 22. Paediatr Drugs. 2025. PMID: 39578320
Similar articles
-
Dexmedetomidine for Less Invasive Surfactant Administration: A Pilot Study.Paediatr Drugs. 2025 Mar;27(2):247-255. doi: 10.1007/s40272-024-00667-1. Epub 2024 Nov 22. Paediatr Drugs. 2025. PMID: 39578320
-
Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient.Pediatr Cardiol. 2013 Apr;34(4):779-85. doi: 10.1007/s00246-013-0659-7. Epub 2013 Feb 24. Pediatr Cardiol. 2013. PMID: 23435789 Review.
-
Laryngeal Mask for Minimally-invasive Surfactant Administration: A Narrative Review.Curr Pediatr Rev. 2025;21(2):111-117. doi: 10.2174/0115733963328784240820062714. Curr Pediatr Rev. 2025. PMID: 39229991 Review.
-
Less invasive beractant administration in preterm infants: a pilot study.Clinics (Sao Paulo). 2016 Mar;71(3):128-34. doi: 10.6061/clinics/2016(03)02. Clinics (Sao Paulo). 2016. PMID: 27074172 Free PMC article. Clinical Trial.
-
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3. Trials. 2020. PMID: 32527290 Free PMC article.
References
-
- Nissimov S, Kohn A, Keidar R, Livne A, Shemer M, Gover A, et al. Dexmedetomidine for less invasive surfactant administration: a pilot study. Paediatr Drugs. 2024. https://doi.org/10.1007/s40272-024-00667-1 . - DOI - PubMed
-
- Maiwald CA, Franz AR, Poets CF, Springer L. Less invasive surfactant administration in preterm infants in tertiary neonatal intensive care units in Germany: a survey. Neonatology. 2024:1–10. https://doi.org/10.1159/000539302 . PMID 39019018.
Publication types
LinkOut - more resources
Full Text Sources